Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

With the safePICO self-fill blood gas syringe, you can improve your mixing and get results you can trust. Mixing ball helps you obtain a homogeneous sample SafeTIPCAP minimizes the risk of blood ...

The BD Neopak™ Glass Prefillable Syringe platform is designed to address key development needs for biologic drugs and our customers have received approval to utilize this platform for more than ...

To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...

Feb. 20, 2024 — The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide. But a new study suggests the drug may ...

Sep. 18, 2024 — People whose diet more closely resembles the MIND diet may have a lower risk of cognitive impairment, according to a new study. Results were similar for Black and white ...

This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster weight-loss drugs might not exist. The work of Joel Habener, a physician ...

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...

Growing awareness of how addiction and trauma are intertwined has birthed a new generation of treatment strategies.

Prior to the measurement demonstration, more than half of the subjects believed that the syringe would be accurate, while only 13% felt that the cup would be an accurate device. Perceptions ...

Reliance Power has announced the settlement of obligations amounting to Rs 3,872.04 crore concerning the guarantee for lenders VIPL. The company also reported that all disputes with CFM Asset ...

The Jhunjhunwala family's wealth in listed firms, which surpassed ₹50,000 crore for the first time in the March quarter, declined by nearly 8% to ₹47,053 crore by the end of the June quarter. Stocks ...